VC
ABBV icon

Veery Capital’s AbbVie ABBV Stock Holding History

Veery Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$231K Sell
884
-7
-0.8% -$1.79K 0.06% 91
2026
Q2 		$224K Buy
+891
New +$192K 0.06% 92
2026
Q1 		– Sell
-876
Closed -$200K – 97
2025
Q4 		$200K Buy
+876
New +$200K 0.06% 93
2025
Q1 		– Sell
-1,416
Closed -$252K – 93
2024
Q4 		$252K Sell
1,416
-59
-4% -$10.8K 0.1% 69
2024
Q3 		$291K Sell
1,475
-120
-8% -$22.4K 0.11% 66
2024
Q2 		$274K Buy
1,595
+10
+0.6% +$1.66K 0.11% 77
2024
Q1 		$289K Buy
1,585
+5
+0.3% +$862 0.12% 75
2023
Q4 		$245K Sell
1,580
-40
-2% -$5.83K 0.11% 76
2023
Q3 		$241K Buy
1,620
+2
+0.1% +$294 0.12% 71
2023
Q2 		$218K Sell
1,618
-28
-2% -$4.11K 0.1% 78
2023
Q1 		$262K Sell
1,646
-38
-2% -$5.81K 0.14% 64
2022
Q4 		$272K Buy
1,684
+63
+4% +$9.66K 0.16% 58
2022
Q3 		$218K Buy
1,621
+26
+2% +$3.73K 0.14% 61
2022
Q2 		$244K Sell
1,595
-147
-8% -$22.5K 0.15% 60
2022
Q1 		$282K Buy
1,742
+143
+9% +$20.8K 0.16% 62
2021
Q4 		$217K Buy
+1,599
New +$189K 0.11% 75

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Veery Capital's ABBV Position: Q3 2026 in Review

Veery Capital reduced its AbbVie (ABBV) stake by 0.79% in Q3 2026, selling an estimated $1.79K and leaving 884 shares worth $231K. The position accounts for 0.06% of the portfolio, ranked #91.

Veery Capital first reported a position in ABBV in Q4 2021 and has held it in 16 quarters since. The position peaked at $291K in Q3 2024. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Veery Capital held 884 shares of AbbVie worth $231K as of Q3 2026.
  • Veery Capital sold 7 AbbVie shares in Q3 2026, an estimated $1.79K.
  • AbbVie made up 0.06% of Veery Capital's portfolio in Q3 2026, its #91 holding.
  • Veery Capital first reported a position in AbbVie in Q4 2021 and has held it in 16 quarters since.
  • Veery Capital's AbbVie position peaked at $291K in Q3 2024.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Veery Capital's 13F filing for Q3 2026, filed 7 Oct 2026.